Efficacy of vaccination against influenza in patients with multiple sclerosis: The role of concomitant therapies. (Q38226945)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25000592%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

title

Efficacy of vaccination against influenza in patients with multiple sclerosis: The role of concomitant therapies (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25000592%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25000592%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25000592%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Emilio Clementi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25000592%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Paolo Pellegrino

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25000592%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Valentina Perrone

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25000592%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Stefania Antoniazzi

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25000592%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Sonia Radice

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25000592%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

language of work or name

English

0 references

publication date

5 July 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25000592%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25000592%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25000592%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25000592%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

page(s)

4730-4735

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25000592%20AND%20SRC:MED&resulttype=core&format=json

Specific aspects of modern life for people with multiple sclerosis: considerations for the practitioner

8 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.06.068

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.06.068

The immunopathology of multiple sclerosis: an overview

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.06.068

Established and novel disease-modifying treatments in multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.06.068

Vaccination against infection in patients with multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.06.068

The risk of relapses in multiple sclerosis during systemic infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.06.068

Vaccinations and the risk of relapse in multiple sclerosis. Vaccines in Multiple Sclerosis Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.06.068

On the association between human papillomavirus vaccine and primary ovarian failure.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.06.068

Human Papillomavirus Vaccine in Patients with Systemic Lupus Erythematosus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.06.068

Acute disseminated encephalomyelitis onset: evaluation based on vaccine adverse events reporting systems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.06.068

Two cases of hallucination in elderly patients due to a probable interaction between flu immunization and tramadol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.06.068

Vaccinations and Risk of Central Nervous System Demyelinating Diseases in Adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.06.068

On the relationship between human papilloma virus vaccine and autoimmune diseases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.06.068

No evidence of a link between multiple sclerosis and the vaccine against the human papillomavirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.06.068

Corticosteroids in the treatment of multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.06.068

Influenza in immunosuppressed populations: a review of infection frequency, morbidity, mortality, and vaccine responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.06.068

A systematic review of the evidence on the effectiveness and risks of inactivated influenza vaccines in different target groups

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.06.068

Hospital admission due to infections in multiple sclerosis patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.06.068

Effects of influenza vaccination and influenza illness on exacerbations in multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.06.068

Influenza virus vaccination of patients with multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.06.068

A multicenter, randomized, double-blind, placebo-controlled trial of influenza immunization in multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.06.068

Influenza vaccination in MS: absence of T-cell response against white matter proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.06.068

Immunotherapies influence the influenza vaccination response in multiple sclerosis patients: an explorative study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.06.068

Preserved antigen-specific immune response in patients with multiple sclerosis responding to IFNβ-therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.06.068

Immune response to influenza vaccine is maintained in patients with multiple sclerosis receiving interferon beta-1a

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.06.068

Protective role of beta interferon in host defense against influenza A virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.06.068

Natalizumab: a review of its use in the management of relapsing-remitting multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.06.068

Humoral immune response to influenza vaccine in natalizumab-treated MS patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.06.068

Evaluation of the lymphocyte trafficking drug FTY720 in SHIVSF162P3-infected rhesus macaques

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.06.068

Treatment with a sphingosine analog does not alter the outcome of a persistent virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.06.068

Cutting edge: contribution of lung-resident T cell proliferation to the overall magnitude of the antigen-specific CD8 T cell response in the lungs following murine influenza virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.06.068

Antigen-specific adaptive immune responses in fingolimod-treated multiple sclerosis patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.06.068

Pharmacodynamic effects of steady-state fingolimod on antibody response in healthy volunteers: a 4-week, randomized, placebo-controlled, parallel-group, multiple-dose study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.06.068

Teriflunomide effect on immune response to influenza vaccine in patients with multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.06.068

Alemtuzumab: evidence for its potential in relapsing-remitting multiple sclerosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.06.068

Immune competence after alemtuzumab treatment of multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.06.068

Impaired response to influenza vaccine associated with persistent memory B cell depletion in non-Hodgkin's lymphoma patients treated with rituximab-containing regimens.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.06.068

Rituximab blocks protective serologic response to influenza A (H1N1) 2009 vaccination in lymphoma patients during or within 6 months after treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.06.068

Poor serological responses upon influenza vaccination in patients with rheumatoid arthritis treated with rituximab

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.06.068

Humoral responses after influenza vaccination are severely reduced in patients with rheumatoid arthritis treated with rituximab

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.06.068

Vaccination against influenza in patients with rheumatoid arthritis: the effect of rituximab on the humoral response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.06.068

Impaired anti-pneumococcal polysaccharide antibody production and invasive pneumococcal infection following heart transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.06.068